Stem Cells Spin S.A. (WSE:SCS)

Market Cap	15.71M +91.0%
Revenue (ttm)	115.74K -30.6%
Net Income	-510.92K
EPS	-0.01
Shares Out	41.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,987
Average Volume	3,725
Open	0.3800
Previous Close	n/a
Day's Range	0.3800 - 0.3800
52-Week Range	0.1400 - 0.5150
Beta	0.49
RSI	42.40
Earnings Date	Feb 13, 2026

About Stem Cells Spin

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wroclaw, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O.

• Industry: Biotechnology & Medical Research
• Sector: Healthcare
• Founded: 2009
• Employees: 1
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: SCS

Financial Performance

In 2024, Stem Cells Spin's revenue was 54,280, a decrease of -87.06% compared to the previous year's 419,322. Losses were -520,267, 237.1% more than in 2023.